Complete Remission of Metastatic Melanoma of the Scalp Following Treatment With Nivolumab Plus Relatlimab

We describe the diagnosis and management of a patient with metastatic nodular melanoma treated with palliative resection of the primary tumor followed by immunotherapy with nivolumab and relatlimab. Four months after his first treatment, he had no evidence of disease on PET scan. He continued to show no evidence of disease at recent follow-up. Treatment of metastatic melanoma of the skin with nivolumab and relatlimab is an effective approach showing greater benefit to patients than nivolumab alone.PMID:38553440 | DOI:10.1177/00031348241241642

Source: The American Surgeon - March 30, 2024 Category: Surgery Authors: Mary E McMinn Kelly A Brister W Shannon Orr Natale T Sheehan Wade O Christopher Source Type: research